Literature DB >> 28935844

High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment.

Susan L Heatley1,2,3, Teresa Sadras1,2, Chung H Kok1,2, Eva Nievergall1,2, Kelly Quek1, Phuong Dang1, Barbara McClure1, Nicola Venn4, Sarah Moore5, Jeffrey Suttle5, Tamara Law4, Anthea Ng3,6, Walter Muskovic4, Murray D Norris4, Tamas Revesz2,3,7, Michael Osborn3,7,8, Andrew S Moore3,9,10, Ram Suppiah11, Chris Fraser3,9, Frank Alvaro3,12, Timothy P Hughes1,2,13, Charles G Mullighan14, Glenn M Marshall3,4,6,8,15, Luciano Dalla Pozza3,6, David T Yeung1,2,13, Rosemary Sutton3,4,8,15, Deborah L White16,2,3,8,17.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28935844      PMCID： PMC5709119          DOI： 10.3324/haematol.2016.162925

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.

Authors:  Shalini C Reshmi; Richard C Harvey; Kathryn G Roberts; Eileen Stonerock; Amy Smith; Heather Jenkins; I-Ming Chen; Marc Valentine; Yu Liu; Yongjin Li; Ying Shao; John Easton; Debbie Payne-Turner; Zhaohui Gu; Thai Hoa Tran; Jonathan V Nguyen; Meenakshi Devidas; Yunfeng Dai; Nyla A Heerema; Andrew J Carroll; Elizabeth A Raetz; Michael J Borowitz; Brent L Wood; Anne L Angiolillo; Michael J Burke; Wanda L Salzer; Patrick A Zweidler-McKay; Karen R Rabin; William L Carroll; Jinghui Zhang; Mignon L Loh; Charles G Mullighan; Cheryl L Willman; Julie M Gastier-Foster; Stephen P Hunger
Journal:  Blood       Date:  2017-04-13       Impact factor: 22.113

2.  BCR-ABL1-like cases in pediatric acute lymphoblastic leukemia: a comparison between DCOG/Erasmus MC and COG/St. Jude signatures.

Authors:  Judith M Boer; João R M Marchante; William E Evans; Martin A Horstmann; Gabriele Escherich; Rob Pieters; Monique L Den Boer
Journal:  Haematologica       Date:  2015-06-04       Impact factor: 9.941

3.  High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.

Authors:  Kathryn G Roberts; Zhaohui Gu; Debbie Payne-Turner; Kelly McCastlain; Richard C Harvey; I-Ming Chen; Deqing Pei; Ilaria Iacobucci; Marcus Valentine; Stanley B Pounds; Lei Shi; Yongjin Li; Jinghui Zhang; Cheng Cheng; Alessandro Rambaldi; Manuela Tosi; Orietta Spinelli; Jerald P Radich; Mark D Minden; Jacob M Rowe; Selina Luger; Mark R Litzow; Martin S Tallman; Peter H Wiernik; Ravi Bhatia; Ibrahim Aldoss; Jessica Kohlschmidt; Krzysztof Mrózek; Guido Marcucci; Clara D Bloomfield; Wendy Stock; Stephen Kornblau; Hagop M Kantarjian; Marina Konopleva; Elisabeth Paietta; Cheryl L Willman; Charles G Mullighan
Journal:  J Clin Oncol       Date:  2016-11-21       Impact factor: 44.544

4.  Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.

Authors:  Richard C Harvey; Charles G Mullighan; I-Ming Chen; Walker Wharton; Fady M Mikhail; Andrew J Carroll; Huining Kang; Wei Liu; Kevin K Dobbin; Malcolm A Smith; William L Carroll; Meenakshi Devidas; W Paul Bowman; Bruce M Camitta; Gregory H Reaman; Stephen P Hunger; James R Downing; Cheryl L Willman
Journal:  Blood       Date:  2010-02-04       Impact factor: 22.113

5.  A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.

Authors:  Monique L Den Boer; Marjon van Slegtenhorst; Renée X De Menezes; Meyling H Cheok; Jessica G C A M Buijs-Gladdines; Susan T C J M Peters; Laura J C M Van Zutven; H Berna Beverloo; Peter J Van der Spek; Gaby Escherich; Martin A Horstmann; Gritta E Janka-Schaub; Willem A Kamps; William E Evans; Rob Pieters
Journal:  Lancet Oncol       Date:  2009-01-08       Impact factor: 41.316

6.  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; Xiaoping Su; Jinghui Zhang; Ina Radtke; Letha A A Phillips; Christopher B Miller; Jing Ma; Wei Liu; Cheng Cheng; Brenda A Schulman; Richard C Harvey; I-Ming Chen; Robert J Clifford; William L Carroll; Gregory Reaman; W Paul Bowman; Meenakshi Devidas; Daniela S Gerhard; Wenjian Yang; Mary V Relling; Sheila A Shurtleff; Dario Campana; Michael J Borowitz; Ching-Hon Pui; Malcolm Smith; Stephen P Hunger; Cheryl L Willman; James R Downing
Journal:  N Engl J Med       Date:  2009-01-07       Impact factor: 91.245

7.  Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.

Authors:  Arian van der Veer; Esmé Waanders; Rob Pieters; Marieke E Willemse; Simon V Van Reijmersdal; Lisa J Russell; Christine J Harrison; William E Evans; Vincent H J van der Velden; Peter M Hoogerbrugge; Frank Van Leeuwen; Gabriele Escherich; Martin A Horstmann; Leila Mohammadi Khankahdani; Dimitris Rizopoulos; Hester A De Groot-Kruseman; Edwin Sonneveld; Roland P Kuiper; Monique L Den Boer
Journal:  Blood       Date:  2013-08-23       Impact factor: 22.113

8.  A revised definition for cure of childhood acute lymphoblastic leukemia.

Authors:  C H Pui; D Pei; D Campana; C Cheng; J T Sandlund; W P Bowman; M M Hudson; R C Ribeiro; S C Raimondi; S Jeha; S C Howard; D Bhojwani; H Inaba; J E Rubnitz; M L Metzger; T A Gruber; E Coustan-Smith; J R Downing; W H Leung; M V Relling; W E Evans
Journal:  Leukemia       Date:  2014-04-30       Impact factor: 11.528

9.  Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia.

Authors:  Judith M Boer; Elisabeth M P Steeghs; João R M Marchante; Aurélie Boeree; James J Beaudoin; H Berna Beverloo; Roland P Kuiper; Gabriele Escherich; Vincent H J van der Velden; C Ellen van der Schoot; Hester A de Groot-Kruseman; Rob Pieters; Monique L den Boer
Journal:  Oncotarget       Date:  2017-01-17

10.  Improving the identification of high risk precursor B acute lymphoblastic leukemia patients with earlier quantification of minimal residual disease.

Authors:  Mawar Karsa; Luciano Dalla Pozza; Nicola C Venn; Tamara Law; Rachael Shi; Jodie E Giles; Anita Y Bahar; Shamira Cross; Daniel Catchpoole; Michelle Haber; Glenn M Marshall; Murray D Norris; Rosemary Sutton
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240
View more
  19 in total

Review 1.  Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia.

Authors:  Richard C Harvey; Sarah K Tasian
Journal:  Blood Adv       Date:  2020-01-14

Review 2.  Is There Etiologic Heterogeneity between Subtypes of Childhood Acute Lymphoblastic Leukemia? A Review of Variation in Risk by Subtype.

Authors:  Lindsay A Williams; Jun J Yang; Betsy A Hirsch; Erin L Marcotte; Logan G Spector
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-02-15       Impact factor: 4.254

3.  Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications.

Authors:  Sabina Chiaretti; Monica Messina; Sara Grammatico; Alfonso Piciocchi; Anna L Fedullo; Filomena Di Giacomo; Nadia Peragine; Valentina Gianfelici; Alessia Lauretti; Rohan Bareja; Maria P Martelli; Marco Vignetti; Valerio Apicella; Antonella Vitale; Loretta S Li; Cyril Salek; Olivier Elemento; Giorgio Inghirami; David M Weinstock; Anna Guarini; Robin Foà
Journal:  Br J Haematol       Date:  2018-04-19       Impact factor: 6.998

Review 4.  New Approaches to Treating Challenging Subtypes of ALL in AYA Patients.

Authors:  Kevin Prescott; Michael Jacobs; Wendy Stock; Joseph Wynne
Journal:  Curr Hematol Malig Rep       Date:  2020-12       Impact factor: 3.952

5.  Low incidence of ABL-class and JAK-STAT signaling pathway alterations in uniformly treated pediatric and adult B-cell acute lymphoblastic leukemia patients using MRD risk-directed approach - a population-based study.

Authors:  Rimvydas Norvilas; Vaidas Dirse; Ruta Semaskeviciene; Orinta Mickeviciute; Egle Gineikiene; Mindaugas Stoskus; Goda Vaitkeviciene; Jelena Rascon; Laimonas Griskevicius
Journal:  BMC Cancer       Date:  2021-03-29       Impact factor: 4.430

Review 6.  Novel Therapies in the Treatment of Adult Acute Lymphoblastic Leukemia.

Authors:  Alexander Gavralidis; Andrew M Brunner
Journal:  Curr Hematol Malig Rep       Date:  2020-08       Impact factor: 3.952

7.  Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.

Authors:  Elisabeth Paietta; Kathryn G Roberts; Victoria Wang; Zhaohui Gu; Georgina A N Buck; Deqing Pei; Cheng Cheng; Ross L Levine; Omar Abdel-Wahab; Zhongshan Cheng; Gang Wu; Chunxu Qu; Lei Shi; Stanley Pounds; Cheryl L Willman; Richard Harvey; Janis Racevskis; Jan Barinka; Yanming Zhang; Gordon W Dewald; Rhett P Ketterling; David Alejos; Hillard M Lazarus; Selina M Luger; Letizia Foroni; Bela Patel; Adele K Fielding; Ari Melnick; David I Marks; Anthony V Moorman; Peter H Wiernik; Jacob M Rowe; Martin S Tallman; Anthony H Goldstone; Charles G Mullighan; Mark R Litzow
Journal:  Blood       Date:  2021-09-16       Impact factor: 25.476

8.  Non-inferior long-term outcomes of adults with Philadelphia chromosome-like acute lymphoblastic leukemia.

Authors:  Hanwool Cho; Yonggoo Kim; Jae-Ho Yoon; Seok Lee; Myungshin Kim; Jaewoong Lee; Gun Dong Lee; Jungok Son; Kyungja Han
Journal:  Bone Marrow Transplant       Date:  2021-04-06       Impact factor: 5.174

9.  Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.

Authors:  Sabina Chiaretti; Monica Messina; Irene Della Starza; Alfonso Piciocchi; Luciana Cafforio; Marzia Cavalli; Akram Taherinasab; Michela Ansuinelli; Loredana Elia; Guglielmo Albertini Petroni; Roberta La Starza; Martina Canichella; Alessia Lauretti; Maria Cristina Puzzolo; Valentina Pierini; Alessandra Santoro; Orietta Spinelli; Valerio Apicella; Saveria Capria; Francesco Di Raimondo; Paolo De Fabritiis; Cristina Papayannidis; Anna Candoni; Roberto Cairoli; Marco Cerrano; Nicola Fracchiolla; Daniele Mattei; Chiara Cattaneo; Antonella Vitale; Enrico Crea; Paola Fazi; Cristina Mecucci; Alessandro Rambaldi; Anna Guarini; Renato Bassan; Robin Foà
Journal:  Haematologica       Date:  2021-06-01       Impact factor: 9.941

Review 10.  Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia.

Authors:  Ilaria Iacobucci; Kathryn G Roberts
Journal:  Genes (Basel)       Date:  2021-05-01       Impact factor: 4.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.